Assessment of the Impact of Polycystic Ovary Syndrome on Women's Sexuality
Launched by UNIVERSITY HOSPITAL, TOULOUSE · Mar 13, 2025
Trial Information
Current as of April 23, 2025
Not yet recruiting
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- For patients in the test group (PCOS):
- • Adults
- • Carriers of medically diagnosed polycystic ovarian syndrome
- • Non-opposition
- For patients in the control group:
- • Adults
- • Not carriers of polycystic ovarian syndrome
- • Unopposed
- Exclusion Criteria:
- • Patient under court protection, guardianship, or curatorship
- • Does not understand or speak French
Trial Officials
Anna Gosset
Principal Investigator
University Hospital of Toulouse
About University Hospital, Toulouse
The University Hospital of Toulouse is a leading academic medical center dedicated to advancing healthcare through innovative research and clinical trials. With a strong emphasis on patient-centered care, the hospital integrates cutting-edge scientific inquiry with comprehensive clinical services. Its multidisciplinary team of healthcare professionals collaborates with renowned researchers to facilitate pioneering studies across various medical fields, aiming to enhance treatment options and improve patient outcomes. As a prominent institution in the region, the University Hospital of Toulouse is committed to fostering an environment of excellence in both education and research within the healthcare community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Toulouse, , France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Related Blog Entries
View all
